Seeking men and women whose multiple myeloma has returned or gotten worse despite treatment for a study comparing investigational drug combinations.
Participants in this study will receive one of three different drug combinations, the standard treatment drug combination, the investigational drug with one other drug (Tal-D), or the investigational drug with two other drugs (Tal-DP) every 28 days.
What we're hoping for
We are comparing whether one investigational drug combination is better than another
ClinicalTrials.gov Identifier: NCT05455320